Securities Registration (section 12(g)) (8-a12g)
14 Fevereiro 2019 - 11:47AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
TODOS
MEDICAL LTD
.
(Exact
name of registrant as specified in its charter)
State
of Israel
|
|
Not
Applicable
|
(State
of incorporation or organization)
|
|
(I.R.S.
Employer Identification No.)
|
1
HaMada St., Rehovot, Israel
|
|
7670301
|
(Address
of principal executive officers)
|
|
(Zip
Code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
Title
of each class
to
be registered
|
|
Name
of each exchange on which
each
class is to be registered
|
None
|
|
None
|
If
this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective
pursuant to General Instruction A.(c), check the following box ☐
If
this form relates to the registration of a class of securities pursuant to Section 12 (g) of the Exchange Act and is effective
pursuant to General Instructions A.(d), check the following box ☒
Securities
Act registration statement file number to which this form relates:
333-
-
209744
Securities
to be registered pursuant to Section 12(g) of the Act:
Ordinary
Shares, with a par value of NIS 0.01 per share
INFORMATION
REQUIRED IN REGISTRATION STATEMENT
Item
1.
Description of Registrant’s Securities to be Registered
A
description of the Registrant’s Ordinary Shares is set forth under the caption “Additional Information” contained
in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on May 15, 2018 (the “Form
20-F”), and is set forth under the caption “Description of Share Capital” in the prospectus included in the
Company’s Registration Statement on Form F-1 (File No. 333-209744) as filed with the Securities and Exchange Commission
on July 27, 2016 (the “Registration Statement”), which descriptions are hereby incorporated by reference to the prior
filings in response to this item.
Item
2.
Exhibits
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Act of 1934, the registrant has duly caused this registration statement on
its behalf by the undersigned, thereto duly authorized.
TODOS
MEDICAL LTD.
By:
|
/s/
Herman Weiss
|
|
|
Name:
Herman Weiss, M.D.
|
|
|
Title:
CEO and Director
|
|
February
14, 2019
Todos Med (CE) (USOTC:TOMDF)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Todos Med (CE) (USOTC:TOMDF)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024